Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX in Recurrent Ovarian Carcinoma
NCT01481701Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Oct 2008
- Primary completion
- May 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in ovarian carcinoma, sponsored by Institut Jules Bordet. Started Oct 2008; status: completed.
02
Drugs
oxaliplatin
03
Conditions
ovarian carcinoma
Beyond the preview
Go deeper on NCT01481701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481701.